2026-01-01 - Analysis Report
Okay, here's a breakdown and analysis of Procter & Gamble (PG) based on the information provided, formatted as requested:

**0) Overview:**

Procter & Gamble Co (PG) is a multinational consumer goods corporation.

**1) Return Rate Comparison (PG vs. VOO):**

*   **PG Cumulative Return:** 25.78%
*   **VOO (S&P 500) Cumulative Return:** 102.21%
*   **Divergence:** -76.4 (current), Range: -80.4 to 24.9, Relative Divergence: 3.8

**Analysis:** PG has significantly underperformed the S&P 500 (VOO) over the period examined. The current divergence is near the lowest end of its historical range, suggesting PG is lagging considerably.  A relative divergence of 3.8 indicates the current divergence is close to the worst it has been relative to its historical fluctuation.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta | Cap(B) |
|------------|--------|--------|--------|------|--------|
| 2024-2026  | 33.0% | 80.1% | -72.0% | 0.0 | 336.9 |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** A projected CAGR of 33.0% is exceptionally high, potentially unsustainable, and likely based on a short period.
*   **MDD (Maximum Drawdown):**  An 80.1% MDD is a very high level of risk.  It indicates a significant potential loss from peak to trough.
*   **Alpha:** -72.0% indicates significant underperformance compared to a benchmark (likely the S&P 500), confirming the underperformance seen above.
*   **Beta:** A Beta of 0.0 suggests that the stock is uncorrelated with the overall market (S&P 500), but can be seen with the high Alpha.
*   **Cap(B):** A market capitalization of 336.9 Billion.

**2) Recent Stock Price Fluctuations:**

*   **Current Close:** 144.05
*   **Last Market Price:** 143.915 (previousClose: 144.05, change: -0.09)
*   **5-day SMA:** 144.206
*   **20-day SMA:** 143.6659
*   **60-day SMA:** 147.167

**Analysis:** The stock is currently trading slightly below its 5-day SMA and 60-day SMA. The price is trading slightly above 20-day SMA.  This suggests a possible short-term downward trend relative to longer-term trends, but these fluctuations are minimal. The last market change of -0.09 is small, indicating no significant immediate volatility.

**3) Index Indicators:**

*   **MRI (Market Risk Indicator):** 0.9 (High Investment Recommended)
*   **RSI (Relative Strength Index):** 63.78 (Close to overbought)
*   **PPO (Percentage Price Oscillator):** 0.1894
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** 0.6 (+): 단기상승 (Short-term increase)
*   **Expected Return (%):** -10.6 (Expected underperformance of the S&P 500 after 2 year investment)

**Analysis:**

*   The MRI of 0.9 suggests that the model views this as a favorable time to invest based on broader market conditions (suggesting low broad market risk).
*   The RSI of 63.78 suggests that the stock is close to overbought territory.
*   The positive PPO suggests the short-term moving average is trending higher than the long-term moving average.
*   The hybrid signal indicates a strong buy recommendation.
*   The short-term increase in relative divergence suggests PG is starting to close the gap with the comparison stock.
*   The negative Expected Return indicates that the model anticipates PG will underperform the S&P 500 over a longer-term (2+ years) horizon.

**4) Recent News & Significant Events:**

*   **Positive Sentiment:** Some articles highlight positive views from Jim Cramer ("Patience Is Going to Pay off") and identify PG as a favorite portfolio stock.
*   **Price Volatility:** Other articles discuss a 2-year low, suggesting recent price weakness.
*   **Institutional Activity:** An article mentions VIRGINIA RETIREMENT SYSTEMS reducing their holdings in PG.
*   **Earnings Discussion:**  An article refers to opinions on Q1 FY26 earnings and price decline.

**Analysis:** The news paints a mixed picture. Analyst recognition as a core holding is positive, but discussions of price declines and institutional selling raise concerns.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (~1.92 on a 1-5 scale)
*   **Target Price:** Average $168.95 (High $186.00, Low $148.00)
*   **Recent Rating Changes:** Not available.

**Analysis:**  Analyst consensus is generally positive, with a "Buy" rating and a target price significantly above the current price. This suggests analysts believe the stock is undervalued and has upside potential. The wide range in target prices ($148 to $186) indicates some uncertainty.

**5) Recent Earnings Analysis:**

| 날짜        | EPS  | 매출      |
| ----------- | ---- | -------- |
| 2025-10-24 | 2    | 22.39 B$ |
| 2025-04-24 | 1.58 | 19.78 B$ |
| 2025-01-22 | 1.94 | 21.88 B$ |
| 2024-10-18 | 1.65 | 21.74 B$ |
| 2025-10-24 | 1.65 | 21.74 B$ |

**Analysis:**

*   Revenue has been fluctuating quarter to quarter.
*   EPS also fluctuate quarter to quarter.
* The last two records are identical (2025-10-24 and 2024-10-18 data).
*   While there doesn't seem to be a clear upward trend, they are not decreasing significantly either.

**6) Financial Information**

Revenue and Profitability:

| Quarter      | Revenue   | Profit Margin |
| ------------ | --------- | --------------- |
| 2025-09-30 | $22.39B | 51.37%         |
| 2025-06-30 | $20.89B | 49.11%         |
| 2025-03-31 | $19.78B | 50.98%         |
| 2024-12-31 | $21.88B | 52.39%         |
| 2024-09-30 | $21.74B | 52.06%         |

Capital and Profitability:

| Quarter      | Equity    | ROE    |
| ------------ | --------- | ------ |
| 2025-09-30 | $53.27B | 8.92% |
| 2025-06-30 | $52.01B | 6.95% |
| 2025-03-31 | $52.27B | 7.21% |
| 2024-12-31 | $51.17B | 9.05% |
| 2024-09-30 | $51.84B | 7.64% |

**Analysis:**

*   **Revenue:** Revenue fluctuates across the quarters.
*   **Profit Margin:** The profit margin also fluctuates.
*   **Equity:** Total equity is relatively stable with modest increase.
*   **ROE (Return on Equity):** ROE fluctuates as well.

**7) Comprehensive Analysis (Summary):**

Procter & Gamble (PG) has underperformed the S&P 500 significantly in the past. While recent news includes some positive analyst sentiment and the MRI/Hybrid Signal suggests a potentially favorable entry point, the negative Expected Return indicates potential underperformance in the future. Revenue, EPS, and ROE are all fluctuating.

**In Summary:** The stock seems to be a mixed bag right now.



**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.